DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Operating Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹2,969 Cr | ₹2,206 Cr | ₹2,369 Cr | ₹3,881 Cr | ₹2,861 Cr |
What is the latest Operating Profit of DIVIS LABORATORIES ?
Year | Operating Profit |
---|---|
Mar2025 | ₹2,969 Cr |
Mar2024 | ₹2,206 Cr |
Mar2023 | ₹2,369 Cr |
Mar2022 | ₹3,881 Cr |
Mar2021 | ₹2,861 Cr |
How is Operating Profit of DIVIS LABORATORIES Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹2,969 Cr | 34.59 | |
Mar2024 | ₹2,206 Cr | -6.88 | |
Mar2023 | ₹2,369 Cr | -38.96 | |
Mar2022 | ₹3,881 Cr | 35.65 | |
Mar2021 | ₹2,861 Cr | - |
Compare Operating Profit of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹162,905.5 Cr | 0.3% | -5.5% | 22.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹379,659.0 Cr | -0.7% | -3.6% | -13.1% | Stock Analytics | |
CIPLA | ₹127,435.0 Cr | -0.8% | 4.1% | -4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,719.0 Cr | 1.1% | -0.5% | 5.2% | Stock Analytics | |
MANKIND PHARMA | ₹105,918.0 Cr | 3.8% | -2.4% | 7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,610.0 Cr | -0.8% | 2.3% | -8.1% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 0.3% |
-5.5% |
22.4% |
SENSEX | 0.8% |
0.2% |
-2% |
You may also like the below Video Courses